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Gilman Drive, La Jolla, CA 92093-0723, USABackground & Aims: Neutrophils are important immune
effectors required for sterile and non-sterile inﬂammatory
responses. However, neutrophils are associated with pathology
in drug-induced liver injury, acute alcoholic liver disease, and
ischemia-reperfusion injury. An understanding of the complex
mechanisms that control neutrophil recruitment to the injured
liver is desirable for developing strategies aimed at limiting
neutrophil-mediated cellular damage.
Methods:Wt, tlr2/, tlr4/, and s100a9/ mice were adminis-
tered CCl4 either acutely (8, 24, 48, or 72 h) or chronically
(8 weeks) and livers investigated by histological (IHC for
neutrophils, ﬁbrogenesis, proliferation, and chemotactic proteins)
or molecular approaches (qRT-PCR for neutrophil chemoattrac-
tant chemokines and cytokines as well as pro-ﬁbrogenic
genes).
Results:Mice lacking TLR2 or S100A9 failed to recruit neu-
trophils to the injured liver and had a defective hepatic
induction of the neutrophil chemokine CXCL-2. Hierarchy
between TLR2 and S100A9 proved to be complex. While
induction of S100A9 was dependent on TLR2 in isolated neu-
trophils, there was a more complicated two-way signalling
cross-talk between TLR2 and S100A9 in whole liver.Journal of Hepatology 20
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a, tumor necrosis factor-a.However, wound-healing and regenerative responses of the
liver were unaffected in these genetic backgrounds as well
as in wild type mice, in which neutrophils were depleted
by infusion of Ly-6G antibody.
Conclusions:We have identiﬁed TLR2 and S100A8/S100A9 as
key regulators of hepatic CXCL-2 expression and neutrophil
recruitment. This novel TLR2-S100A9-CXCL-2 pathway may be
of use in development of new strategies for selectively manipu-
lating neutrophils in liver disease without impairing normal
wound healing and regenerative responses.
 2013 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.Introduction
Hepatic inﬁltration by neutrophils and their subsequent activa-
tion are a rapid response to sterile and non-sterile tissue injury
[1]. Following extravasation into the parenchyma, neutrophils
directly interact with hepatocytes via their surface LFA-1
(CD11b/CD18) and Mac-1 receptors. Engagement of the latter
stimulates production of reactive oxygen species (ROS), which
is important for host-defence but can be cytotoxic; neutrophil-
derived ROS can diffuse into adjacent hepatocytes and either
directly induce cellular damage or more likely cause mitochon-
drial dysfunction and necrosis [2]. Additionally degranulation of
neutrophils results in the release of proteases that can contribute
to hepatocellular damage and death [3]. Clinical conditions, with
evidence for neutrophil activation and hepatocellular death,
include alcoholic hepatitis [4], acetaminophen (APAP)-induced
acute liver injury [2], and ischemia-reperfusion injury [5]. The
extent of neutrophil inﬁltration in alcoholic hepatitis is correlated
with disease severity [6]. There is experimental evidence for neu-
trophil-mediated cell death in liver injury models including acute
alcoholic hepatitis [7]. By contrast, a role for neutrophils in
chronic liver disease is less clear. Cirrhosis is associated with ele-
vated levels of circulating and hepatic neutrophil chemokines
such as IL-8, while hepatic neutrophils are also described to be14 vol. 60 j 782–791
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a feature of progressive ﬁbrotic disease [8]. However, experimen-
tal models of biliary liver disease suggest a minor if any func-
tional contribution of neutrophils to ﬁbrogenesis [9]. But it
remains likely that persistence of activated neutrophils in chronic
liver disease is contributory to disease progression and outcome,
including hepatocellular carcinoma [10]. As such, a better under-
standing of the regulation of neutrophil recruitment is important,
as is the identiﬁcation of molecular targets that might be
exploited for therapeutic manipulation of neutrophils in diseased
tissues.
McDonald et al. reported that a dynamic multistep network of
directional cues serves to recruit neutrophils to sites of cellular
damage under sterile conditions. At least three key mechanisms
were identiﬁed: (i) Activation of the Nlrp3 inﬂammasome by
ATP released from necrotic cells, which promoted adherence of
circulating neutrophils to sinusoids, (ii) generation of a chemo-
kine gradient directing neutrophils to the site of cellular damage,
and (iii) formyl-peptide signals from necrotic cells that help
guide neutrophils through the sinusoids to the site of injury
[11]. Activation of Toll-like-receptors (TLRs) also facilitates neu-
trophil recruitment and recent studies have highlighted the
increased expression and functional importance of TLR2, 4, and
9 in acute and chronic liver disease [12].
Here we have used a mouse gene knockout approach to
investigate the role of TLR2 in the response to toxic (carbon tet-
rachloride, CCl4) liver injury. We demonstrate a critical role for
TLR2 (but not TLR4) for recruitment of neutrophils to the
injured liver. TLR2 was required for expression of the CXCL-1
(KC) CXCL-2 (MIP-2) neutrophil chemokines by hepatic macro-
phages. In addition, the myeloid-related proteins MRP-8
(S100A8) and MRP-14 (S100A9) were also induced in response
to liver injury and were responsive to TLR2 activation. Under
normal physiological conditions S100A8 and S100A9 are
expressed in neutrophils, monocytes, and eosinophils [13], but
following tissue damage they are induced in epithelial and
endothelial cells and upon secretion act as powerful leukocyte
chemoattractants [14]. S100A8 and S100A9 form functional
homodimers and heterodimers (the latter known as Calprotec-
tin). Mice lacking S100A9 also lack S100A8 due to instability
of the S100A8 protein in the absence of S100A9 protein; hence
s100a9/ mice fail to express Calprotectin under resting or
injury-induced states. We show here that s100a9/ mice dis-
play a similar phenotype to tlr2/ animals with defective
induction of hepatic CXCL-2 induction and reduced neutrophil
recruitment. However, neither deﬁciency in TLR2 or S100A9 or
antibody-mediated neutrophil depletion had any impact on
activation of hepatic stellate cells (HSCs) or wound-repair.
Hence, a hepatic TLR2-S100A9-CXCL-2 pathway may be an
interesting target for the selective manipulation of neutrophils
in acute and chronic liver disease.
Materials and methods
In vivo models of rodent acute liver injury and ﬁbrogenesis
Wt, tlr2/ [15], tlr4/ [16], and s100a9/ [17] mice were provided by Prof M.
Karin, Prof E. Seki and Prof N. Hogg. Single intraperitoneal injection of CCl4 at a
dose of 2 ll (CCl4:olive oil, 1:1 [v:v])/g body weight was administered for 8, 24,
48, and 72 h to 8–10 week old male littermates. 8–10 week old male C57Bl/6
mice were injected with pure LTA at 250 lg/mouse 30 min prior to acute CCl4
challenge. Mice were pre-treated with Ly-6G or IgG control antibody for 12 h
before LTA injection. Animals were culled at 48 h post-CCl4 injection. At least 5
animals were used per treatment group.Journal of Hepatology 201In vivo models of rodent chronic liver injury and ﬁbrogenesis
8–10 week old male s100a9/ and wt littermate mice were injected with CCl4
intraperitoneally (IP) twice a week at a dose of 2 ll (CCl4:olive oil, 1:3, [v:v])/g
body weight during 8 weeks or bile duct ligation was performed as previously
described for 14 days [18]. For the chronic CCl4 model, animals were culled either
at 24 h (peak) or 7 days (recovery) after the last CCl4 injection. At least 7 animals
were used per group of treatment.
Statistical analysis
Data is expressed as mean ± S.E.M. (standard error). A minimum of 5 animals per
group were used in the experimental animal models. All p values were calculated
using a two tailed paired Student’s t test or a one way ANOVA and ⁄p 60.05
or ⁄⁄p 60.01 was considered statistically signiﬁcant.Results
Neutrophils are a common feature of human liver disease
Prior to investigating the role of TLRs in neutrophil recruitment
we conﬁrmed that these cells are present in diseased human
liver. As shown in representative Neutrophil elastase+ (NE+)
stained liver sections (Fig. 1A), neutrophils are present in acute
alcoholic hepatitis (AAH), acetaminophen acute liver failure
(APAP ALF), primary biliary cirrhosis (PBC), primary sclerosing
cholangiatis (PSC), alcoholic liver disease (ALD), and non-alco-
holic steatohepatitis (NASH) suggestive of neutrophils being a
common feature of the diseased liver irrespective of the cause
of the underlying injury. As anticipated APAP was associated with
high numbers of hepatic neutrophils relative to chronic liver dis-
eases, of the latter neutrophils were highest in PBC livers
(Fig. 1B).
TLR2 is essential for optimal neutrophil recruitment to the damaged
liver
To determine if TLR2 is a regulator of neutrophil recruitment we
administered CCl4 to tlr2/ mice and compared their acute
response with wt and tlr4/ mice at 24, 48, and 72 h. Serum
ALT measurements indicated no signiﬁcant differences in the
degree of hepatic damage between the three phenotypes with
the exception of tlr4/ at 72 h where there was a trend towards
higher levels of damage (Supplementary Fig. 1A). IHC staining
(NIMP-1) and counting of neutrophils demonstrated the antici-
pated appearance of high numbers of hepatic neutrophils at
24 h in wt and tlr4/ injured mice (Fig. 1C). By contrast there
was a 3-fold lower number of neutrophils in tlr2/ livers at this
time point. In all genotypes, hepatic neutrophils declined to near
base-line levels by 48 h. To assess effects of TLR deletions on the
acute ﬁbrogenic and regenerative responses following liver dam-
age we performed morphometric analysis of a-SMA+ myoﬁbro-
blasts (Fig. 1D) and counted PCNA+ hepatocytes (Fig. 1E)
respectively. As expected these IHC markers were elevated at
48 and 72 h but no differences were observed between the three
genotypes suggesting normal wound-healing in tlr2/ liver. A
normal ﬁbrogenic response in tlr2/ was conﬁrmed by similar
induction of transcripts for a-SMA and Collagen I between the
genotypes (Supplementary Fig. 1B–C). We conclude that TLR2 is
required for optimal recruitment of neutrophils to the hepatic
parenchyma, but is dispensable for subsequent wound-repair/
ﬁbrogenesis and regenerative responses. However, as previously4 vol. 60 j 782–791 783
0200
400
600
800
1000
1200
AAH APAP PBC PSC ALD NASH
wt
tlr2 -/-
-/-tlr4
PSC NASHALD
LTA  
48 h CCl4  
-
+
-
+
+
+
+
+
0.0
2.5
5.0
7.5
10.0
12.5
LTA  
48 h CCl4  
IgG
Ly-6G
**
**
- - + +
0
2
4
6
8
10
12
14
LTA  
48 h CCl4  + + + +
F
PBCA
wt
tlr2 -/-
-/-tlr4
C
0
5
10
15
20
A
ve
r. 
N
IM
P
-1
+ 
ce
lls
/fi
el
d
25
*
** *
*
*
*
*
00
2
4
6
8
10
A
ve
r. 
%
 α
-S
M
A
+ 
ar
ea
/fi
el
d
**
**
**
**
**
wt
tlr2 -/-
-/-tlr4
D
10
20
30
40
50
60
70
80
A
ve
r. 
P
C
N
A
+ 
ce
lls
/fi
el
d
E
** **
**
**
**
**
A
ve
r. 
N
IM
P
-1
+ 
ce
lls
/fi
el
d
A
ve
r. 
%
 α
-S
M
A
+ 
ar
ea
/fi
el
d
 R
LT
D
 fo
ld
 v
s.
 4
8 
h 
C
C
l 4 
Ig
G
α-SMA
G H
tlr2wt tlr4-/- -/-
-
+
+
+
+
+
0.0
0.5
1.0
1.5
2.0
2.5
APAP ALFAAH
A
ve
r. 
N
E
+ 
ce
lls
/fi
el
d
B
O Oil 24 h CCl4 48 h CCl4 72 h CCl4
O Oil 24 h CCl4 48 h CCl4 72 h CCl4 O Oil 24 h CCl4 48 h CCl4 72 h CCl4
-
+
Research Article
784 Journal of Hepatology 2014 vol. 60 j 782–791
JOURNAL OF HEPATOLOGY
published [19,20] neutrophil depletion dramatically reduced
APAP-induced liver damage (Supplementary Fig. 2A–C).
Since the role of neutrophils has not been formally addressed
in the CCl4 injury model, we determined the effects of Ly-6G anti-
body-mediated depletion of circulating neutrophils on ﬁbrogene-
sis at the 48 h time point in wt animals. Ly-6G treatment led to a
dramatic reduction in numbers of circulating and CCl4-induced
hepatic neutrophils (Fig. 1F and Supplementary Fig. 3A–C). Spec-
iﬁcity was conﬁrmed by lack of effect of Ly-6G on hepatic macro-
phages (Supplementary Fig. 3D). IHC and mRNA analysis of
a-SMA revealed no requirement for neutrophils in the ﬁbrogenic
response (Fig. 1G and H). Moreover, treatment of CCl4-injured
mice with the TLR2 agonist LTA was also without effect on
ﬁbrogenesis (Fig. 1G and H).
TLR2 is required for hepatic induction of neutrophil attractants
CXCL-2 and TNF-a
Expression CXCL-1 and CXCL-2 can be found across a broad range
of human liver injuries implicating these chemokines in the
recruitment of hepatic neutrophils (Supplementary Fig. 4). The
expression of CXCL-1 and CXCL-2 and the murine neutrophil che-
moattractants TNF-a and S100A9 was examined in CCl4 damaged
mouse livers. Hepatic CXCL-2, TNF-a, and S100A9 transcripts were
all robustly induced in wt at 24 h post-CCl4 with subsequent
decline in their expression (Fig. 2A and B). By contrast, CXCL-1
was only modestly induced and peaked at 48 h (Fig. 2B). Absence
of TLR2 was associated with blunted CXCL-2 and TNF-a
responses (Fig. 2A), but at this time point had no impact on the
induction of S100A9 (Fig. 2B). ELISA conﬁrmed TLR2 is required
for induction of CXCL-2 protein expression (Supplementary
Fig. 1D). We next determined the combined effects of LTA and
CCl4 on hepatic neutrophil chemoattractants comparing wt with
tlr2/. For this experiment an earlier 8 h time point was exam-
ined, which precedes peak neutrophil accumulation. This time
point was associated with a modest increase in numbers of hepa-
tic neutrophils in wt mice which was stimulated 3-fold by
co-administration of LTA (Fig. 2C). Neutrophil recruitment at
8 h was blunted in tlr2/ mice injured with CCl4 and was also
reduced in tlr2/ mice co-administered LTA and CCl4. These data
conﬁrm that TLR2 is an important immune trigger for neutrophil
recruitment to the liver. Hepatic CXCL-2 was stimulated by a fur-
ther 3-fold in mice co-administered LTA and CCl4, however this
induction was noticeably absent in tlr2/ animals (Fig. 2G).
IHC analysis conﬁrmed that CXCL-2 was mainly conﬁned to liver
macrophages (Fig. 2G). CXCL-1 (Fig. 2D) and TNF-a (Fig. 2E) were
only modestly induced at 8 h and no dramatic differences in their
expression were noticeable between wt and tlr2/ genotypes.
Measurement of S100A8 and S100A9 transcripts revealed no sig-
niﬁcant changes at 8 h post-CCl4. However, co-administration of
LTA and CCl4 was associated with elevated neutrophil recruit-
ment (Fig. 2C and G) and with CXCL-2 induced S100A8 and
S100A9 expression by 6- and 4-fold respectively (Fig. 2F and H).
This latter effect was only observed in wt indicating that under
these conditions TLR2 was required for induction of Calprotectin.Fig. 1. Tlr2/ presents deﬁcient neutrophil recruitment with no effect on the wound
IHC from a minimum of 4 different human biopsies of (A) AAH, APAP ALF, PBC, PSC, ALD
representative pictures at 400, (D) morphometric analysis of a-SMA+ area/ﬁeld, (E) ave
48, 72 h. (F) Average NIMP-1+ cells/ ﬁeld, (G) morphometric analysis of a-SMA+ area/ﬁel
for 12 h and then treated with CCl4 for 48 h ± LTA. ⁄p 60.05; ⁄⁄p 60.01.
Journal of Hepatology 201This result contrasted with our earlier observation (Fig. 2B)
where CCl4 alone at 24 h post-injury was associated with TLR2-
independent induction of S100A9 (Fig. 2B). We therefore con-
ﬁrmed the potential for TLR2 activation to stimulate S100A9 by
treating cultured ex vivo neutrophils with LTA. This treatment
increased S100A9 expression at the protein level and could be
blocked by incubation of neutrophils with anti-TLR2 antibody
(Supplementary Fig. 5A). Phosphorylation of P38 was monitored
as a positive assay control. As expected, P38 phosphorylation
was successfully blocked by an anti-TLR2 antibody after LTA
treatment (Supplementary Fig. 5B). IHC analysis conﬁrmed that
liver injury was associated with de novo induced expression of
S100A9 in hepatocytes in addition to the anticipated expression
in neutrophils (Fig. 2H).
Induction of neutrophil recruitment and hepatic CXCL-2 requires
Calprotectin
As Calprotectin is induced by CCl4 we were interested to deter-
mine a role in the hepatic wound healing response. However,
absence of S100A9 made no impact on CCl4-induced liver damage
(Fig. 3A) or the ﬁbrogenic response as determined by hepatic
aSMA protein expression (Fig. 3B), morphometry of aSMA+,
and Collagen I gene expression (Fig. 3C–D). Normal induction of
PCNA expression in s100a9/ livers suggested no major role for
S100A9 in the regenerative response (Fig. 3B). However,
CCl4-induced neutrophil recruitment was defective in s100a9/
livers (Fig. 3E). This phenotype was associated with a trend
towards reduced expression of CXCL-2 at 24 h (Fig. 3F), which
by IHC staining was mainly expressed in macrophages (Fig. 3G).
CXCL-1 was also reduced at the later time point of 48 h
(Fig. 3H) and was expressed in hepatocytes and macrophages
(Supplementary Fig. 6A). These data suggest that both TLR2 and
Calprotectin function in the recruitment of hepatic neutrophils
and are required for optimal induction of CXCL-2. Given this sig-
nalling cross-talk, we determined if hepatic TLR2 expression is
inﬂuenced by S100A8/S100A9. As shown in Supplementary
Fig. 6B, we observed no impact of S100A9 knockout on hepatic
TLR2 transcript expression in control uninjured (olive oil) or
24 h injured mice, this suggests that Calprotectin does not oper-
ate upstream of TLR2 in controlling neutrophil recruitment. How-
ever, we did observe a substantial 10-fold induction of TLR2
transcript at 48 h in wt liver, which was completely absent in
s100a9/ mice. We conclude that at the whole tissue level there
is likely to be complex time-dependent, two-way signalling
cross-talk between TLR2 and Calprotectin.
Defective neutrophil recruitment and CXCL-2 expression do not
impact on wound-healing in chronic liver disease
To determine the impact of suppressed neutrophil recruitment in
a more complex model of chronic liver disease we investigated
the effects of S100A9 deletion on wound-repair and regeneration
in an 8-week model of iterative CCl4-induced liver disease. Two
end-points were selected; 1-day (peak disease) and 7-dayhealing response. Representative 200 photomicrographs of neutrophil elastase
, and NASH. (B) Average NE+ cells/100 ﬁeld. (C) Average NIMP-1+ cells/ﬁeld and
rage PCNA+ cells/ﬁeld of wt, tlr2/, tlr4/ mice after acute CCl4 treatment for 24,
d and (H) a-SMA mRNA expression in liver from wt pre-treated with Ly-6G or IgG
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(recovery) post-ﬁnal CCl4 administration, this to allow us to
determine effects of S100A9 deletion on wound healing and sub-
sequent spontaneous repair and regeneration following cessation
of injury. As anticipated we observed high numbers of hepatic
neutrophils in wt mice at peak injury that dramatically declined
with recovery (Fig. 4A). Numbers of neutrophils at peak injury in
s100a9/ livers were at roughly 50% of the levels found in wt,
again these declined to base-line with recovery. Despite this
reduced level of hepatic neutrophils we observed no differences
in collagen deposition by Sirius Red staining (Fig. 4B and D),
numbers of hepatic macrophages by F4/80 IHC (Fig. 4C and D),
numbers of aSMA+ myoﬁbroblasts (Fig. 4D and E) or expression
of collagen I mRNA and aSMA protein (Fig. 4E and F). In addition,
we detected similar levels of PCNA between wt and s100a9/ liv-
ers (Fig. 4F). qRT-PCR proﬁling (Fig. 4G) revealed high levels of
cytokines (IL6, TNF-a) and chemokines (CCL-2, CCL-5, CXCL-1,
and CXCL-2) at peak disease, all of which declined to low base-
line levels with recovery. In s100a9/ we observed signiﬁcantly
reduced levels of CXCL-2 compared with wt, this in agreement
with our earlier observation of reduced chemokine expression
in acute injury (Fig. 3F). Additionally a trend towards lower
expression of the neutrophil attractants TNF-a and CXCL-1 was
also noted in the absence of S100A9. ELISA measurements con-
ﬁrmed the induction of CXCL-2 and the requirement of s100a9
for this response (Fig. 4H). BDL-induced ﬁbrosis was also rela-
tively unaffected in s100a9/ mice (Supplementary Fig. 7A–D)
although we did observe a non-signiﬁcant trend towards reduced
levels of collagen deposition. These data suggest that in chronic
liver disease targeting neutrophil recruitment via the TLR2/Cal-
protectin/CXCL-2 pathway would have minimal impact on
efﬁciency of wound-repair and regeneration.
Discussion
Neutrophils are recruited to the hepatic sinusoids in acute liver
injury and then migrate into the hepatic parenchyma in response
to macrophage-derived CXC chemokines and other immune
mediators released from dying/dead hepatocytes [21]. In alco-
holic liver disease, APAP-induced acute liver injury and during
ischemia-reperfusion, activated neutrophils within the paren-
chyma are potentially harmful as they can promote hepatocellu-
lar stress and necrosis contributing to liver failure [2]. Hence,
illuminating the molecular regulators of neutrophil recruitment
and extravasation is of interest for a better understanding of
hepatic immunity and for developing strategies aimed at limiting
collateral tissue damage caused by activated neutrophils. Here
we report that TLR2 and S100A9 are required in a non-redundant
manner for optimal induction of hepatic CXCL-2 and recruitment
of neutrophils in response to hepatocellular damage. The expres-
sion of TLR2 has been detected on a number of different resident
liver cell types including Kupffer cells, hepatic stellate cells, hepa-
tocytes, cholangiocytes and sinusoidal endothelial cells [22]. In
previous studies by the Seki lab employing TLR2 bone marrow
chimeric mice, Kupffer cells were found to be the dominant cell
type through which hepatic inﬂammation is mediated by TLR2
[23]. Most likely from our IHC studies CXCL-2 is chieﬂy inducedFig. 3. S100A9 is required for an effective neutrophil recruitment and hepatic expr
western blot of whole liver lysates, (C) morphometric analysis of a-SMA+ area/ﬁeld, (
representative pictures at 400, (F) CXCL-2mRNA expression, (G) CXCL-2 representative I
mRNA expression in whole liver of wt and s100a9/ mice after acute CCl4 treatment fo
788 Journal of Hepatology 201within Kupffer cells via intracellular TLR2 signalling with more
modest, possibly secondary expression appearing in damaged
hepatocytes, which would be in agreement with other reports
in the literature [24,25]. However the cellular source of CXCL-2
may be dependent on the nature of the liver injury. Xu et al.
showed that a-Napthylisothiocyanate (ANIT), which causes
severe cholestatic injury in the mouse was associated with rapid
induction of CXCL-2 primarily from periportal hepatocytes [26].
Although, of note, the authors observed only a modest induction
of CXCL-2 in cultured hepatocytes directly exposed to ANIT [26].
S100A9 is mainly associated with granulocytes, but was induced
along with S100A8 in hepatocytes following liver damage. This
observation is in keeping with others who have documented
inducible expression of S100A8 and S100A9 in epithelial cells of
injured tissues [14]. Furthermore, S100A8 and S100A9 are
expressed by HCC tumour cells as well as by other tumours of
epithelial origin including lung, breast, gastric, and prostate
[27]. Hence, we propose that dual signalling via TLR2 on Kupffer
cells and S100A8/S100A9 from hepatocytes combine to generate
CXCL-2 chemokine gradients for guidance of neutrophils into the
hepatic sinusoids and parenchyma respectively.
Marques et al. recently showed that CXCR2 antagonism in
mice injured with APAP suppressed hepatic neutrophil recruit-
ment by 50% [28]. In this latter study combined antagonism of
CXCR2 and FPR1 resulted in more substantive suppression of
neutrophil migration; this is in agreement with McDonald et al.,
who reported a cooperation between CXCR2 chemokines and
mitochondrial formyl peptides for guidance of neutrophils to
sites of necrosis [29]. In the ANIT cholestasis model a 50% reduc-
tion in the inﬂux of neutrophils was observed in cxcr2/ mice
[26], which closely agrees with data from Marques et al. when
employing a pharmacological approach for blockade of CXCR2
in the APAP model. Hence, CXCR2 chemokines are not absolutely
required for neutrophil inﬂux to injured liver, but instead cooper-
ate with other neutrophil attractants such as ATP, formyl pep-
tides and TNF-a to ensure optimal neutrophil guidance [11].
Our data build on these ﬁndings by revealing that TLR2 and
S100A8/S100A9 operate in neutrophil guidance most likely
upstream of CXCL-2 (and to a lesser extent CXCL-1 and TNF-a)
by regulating its expression in response to tissue damage. Signal-
ling pathways downstream of TLR2 and S100A8/S100A9 both
converge on activation of NF-jB, for which CXCL-1 and CXCL-2
are known target genes [30], this providing one plausible expla-
nation for the similar regulatory functions of TLR2 and S100A8/
S100A9 in neutrophil recruitment.
A key ﬁnding of our work was that acute repair and regener-
ative responses were normal in TLR2 and S100A9 knockout mice,
and furthermore ﬁbrosis caused by chronic injury with CCl4 was
unaffected in S100A9 knockouts. Previous studies have shown lit-
tle or no inﬂuence of neutrophilic inﬂammation on ﬁbrosis [9], in
addition ANIT-induced ﬁbrosis is unaffected in cxcr2/ animals
[26]. Hence, our data are supportive of neutrophils and CXCR2
chemokines being redundant for ﬁbrogenesis. The role of TLR2
in ﬁbrosis is unclear since there are apparently contradictory data
in the recent literature. Seki et al., observed that while tlr4/
mice are attenuated for liver ﬁbrosis induced by CCl4 and BDL,ession of CXCL-2. (A) Serum analysis of ALT levels, (B) a-SMA, PCNA and b-actin
D) Col1A1 mRNA expression in whole liver, (E) average NIMP-1+ cells/ﬁeld with
HC pictures at 400, cytosolic macrophage staining (black arrows), and (H) CXCL-1
r 24, 48, 72 h. ⁄p 60.05; ⁄⁄p 60.01.
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by contrast tlr2/ developed BDL-induced ﬁbrosis in a similar
manner to wt mice [31]. However, in subsequent studies Hart-
mann and colleagues found that TLR2 deﬁcient mice re-derived
and housed in speciﬁc pathogen-free (sp-f) conditions were resis-
tant to BDL- and CCl4-induced ﬁbrosis [32]. In the latter study, it
was suggested that TNF-a produced by TLR2+ monocytes in the
intestinal lamina propria mediates intestinal barrier disruption,
resulting in translocation of bacteria and their products across
the mucosal barrier and on to the liver via the portal circulation,
where they enhance ﬁbrogenesis. The Seki lab also recently
reported that tlr2/ mice are protected from progression of
CDAA-induced NASH to ﬁbrosis and they suggested this was
due to an impaired inﬂammatory reaction associated with
reduced expression of NLRP3 inﬂammasome components [23].
Hence, neither of these latter studies suggest a direct role for
TLR2 in hepatic stellate cell activation, but instead indicate that
absence of TLR2 results in failure of inﬂammatory pathways that
are upstream of ﬁbrosis. Our observation of normal induction of
a-SMA and collagen I expression in tlr2/ following acute injury
with CCl4 argues against a direct role for TLR2 in hepatic stellate
cell activation.
In summary we have advanced current knowledge regarding
the mechanisms by which neutrophils are guided to the injured
liver and identiﬁed TLR2 and S100A8/S100A9 as key regulators
of hepatic CXCL-2 expression and neutrophil recruitment. This
new information may be of use in developing strategies for
limiting neutrophil-mediated tissue damage in acute liver
injuries.Conﬂict of interest
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